Sandrine Boulet1, Moreno Ursino1, Peter Thall2, Bruno Landi3, Céline Lepère3, Simon Pernot3, Anita Burgun1,4, Julien Taieb3, Aziz Zaanan3, Sarah Zohar1, Anne-Sophie Jannot1,4. 1. INSERM U1138, University Paris Descartes, Sorbonne University, Paris, France. 2. Department of Biostatistics, M.D. Anderson Cancer Center, Houston, Texas, USA. 3. Department of Digestive Oncology, Hôpital européen Georges-Pompidou, AP-HP, Paris, France. 4. Department of Statistics, Medical Informatic and Public Health, Hôpital européen Georges-Pompidou, AP-HP, Paris, France.
Abstract
BACKGROUND: Building tools to support personalized medicine needs to model medical decision-making. For this purpose, both expert and real world data provide a rich source of information. Currently, machine learning techniques are developing to select relevant variables for decision-making. Rather than using data-driven analysis alone, eliciting prior information from physicians related to their medical decision-making processes can be useful in variable selection. Our framework is electronic health records data on repeated dose adjustment of Irinotecan for the treatment of metastatic colorectal cancer. We propose a method that incorporates elicited expert weights associated with variables involved in dose reduction decisions into the Stochastic Search Variable Selection (SSVS), a Bayesian variable selection method, by using a power prior. METHODS: Clinician experts were first asked to provide numerical clinical relevance weights to express their beliefs about the importance of each variable in their medical decision making. Then, we modeled the link between repeated dose reduction, patient characteristics, and toxicities by assuming a logistic mixed-effects model. Simulated data were generated based on the elicited weights and combined with the observed dose reduction data via a power prior. We compared the Bayesian power prior-based SSVS performance to the usual SSVS in our case study, including a sensitivity analysis using the power prior parameter. RESULTS: The selected variables differ when using only expert knowledge, only the usual SSVS, or combining both. Our method enables one to select rare variables that may be missed using only the observed data and to discard variables that appear to be relevant based on the data but not relevant from the expert perspective. CONCLUSION: We introduce an innovative Bayesian variable selection method that adaptively combines elicited expert information and real world data. The method selects a set of variables relevant to model medical decision process.
BACKGROUND: Building tools to support personalized medicine needs to model medical decision-making. For this purpose, both expert and real world data provide a rich source of information. Currently, machine learning techniques are developing to select relevant variables for decision-making. Rather than using data-driven analysis alone, eliciting prior information from physicians related to their medical decision-making processes can be useful in variable selection. Our framework is electronic health records data on repeated dose adjustment of Irinotecan for the treatment of metastatic colorectal cancer. We propose a method that incorporates elicited expert weights associated with variables involved in dose reduction decisions into the Stochastic Search Variable Selection (SSVS), a Bayesian variable selection method, by using a power prior. METHODS: Clinician experts were first asked to provide numerical clinical relevance weights to express their beliefs about the importance of each variable in their medical decision making. Then, we modeled the link between repeated dose reduction, patient characteristics, and toxicities by assuming a logistic mixed-effects model. Simulated data were generated based on the elicited weights and combined with the observed dose reduction data via a power prior. We compared the Bayesian power prior-based SSVS performance to the usual SSVS in our case study, including a sensitivity analysis using the power prior parameter. RESULTS: The selected variables differ when using only expert knowledge, only the usual SSVS, or combining both. Our method enables one to select rare variables that may be missed using only the observed data and to discard variables that appear to be relevant based on the data but not relevant from the expert perspective. CONCLUSION: We introduce an innovative Bayesian variable selection method that adaptively combines elicited expert information and real world data. The method selects a set of variables relevant to model medical decision process.
Entities:
Keywords:
Bayesian variable selection; clinical relevance weights elicitation; electronic health record; power prior method; repeated measures
Authors: Federico Innocenti; Richard L Schilsky; Jacqueline Ramírez; Linda Janisch; Samir Undevia; Larry K House; Soma Das; Kehua Wu; Michelle Turcich; Robert Marsh; Theodore Karrison; Michael L Maitland; Ravi Salgia; Mark J Ratain Journal: J Clin Oncol Date: 2014-06-23 Impact factor: 44.544
Authors: J C-H Yang; L V Sequist; C Zhou; M Schuler; S L Geater; T Mok; C-P Hu; N Yamamoto; J Feng; K O'Byrne; S Lu; V Hirsh; Y Huang; M Sebastian; I Okamoto; N Dickgreber; R Shah; A Märten; D Massey; S Wind; Y-L Wu Journal: Ann Oncol Date: 2016-09-06 Impact factor: 32.976
Authors: Gertraud Stocker; Ulrich T Hacker; Frédéric Fiteni; Jestinah John Mahachie; Arnaud D Roth; Eric Van Cutsem; Marc Peeters; Florian Lordick; Murielle Mauer Journal: Eur J Cancer Date: 2018-06-15 Impact factor: 9.162
Authors: Laura Visa; Paula Jiménez-Fonseca; Elena Asensio Martínez; Raquel Hernández; Ana Custodio; Manuel Garrido; Antonio Viudez; Elvira Buxo; Ignacio Echavarria; Juana María Cano; Ismael Macias; Montserrat Mangas; Eva Martínez de Castro; Teresa García; Felipe Álvarez Manceñido; Ana Fernández Montes; Aitor Azkarate; Federico Longo; Asunción Díaz Serrano; Carlos López; Alicia Hurtado; Paula Cerdá; Raquel Serrano; Aitziber Gil-Negrete; Alfonso Martín Carnicero; Paola Pimentel; Avinash Ramchandani; Alberto Carmona-Bayonas Journal: J Geriatr Oncol Date: 2017-12-11 Impact factor: 3.599
Authors: Jessica D Tenenbaum; Paul Avillach; Marge Benham-Hutchins; Matthew K Breitenstein; Erin L Crowgey; Mark A Hoffman; Xia Jiang; Subha Madhavan; John E Mattison; Radhakrishnan Nagarajan; Bisakha Ray; Dmitriy Shin; Shyam Visweswaran; Zhongming Zhao; Robert R Freimuth Journal: J Am Med Inform Assoc Date: 2016-04-23 Impact factor: 4.497
Authors: Jessica M Schwartz; Amanda J Moy; Sarah C Rossetti; Noémie Elhadad; Kenrick D Cato Journal: J Am Med Inform Assoc Date: 2021-03-01 Impact factor: 4.497